ScienceDex / Researcher record
Detke, Michael J.
- Embera Neurotherapeutics, Inc. (no department on record)
From the FY2016 NIH awards this investigator leads as contact PI. The department is the award's.
- Program Leader
- Top 5% Funded
- Early Career
NIH Funding · FY2016
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2016 | $4,057,614 | 1 | #841 |
| 2018 | $3,762,556 | 1 | #934 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2016 · selected1 record
- FY20181 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2016 through FY2018Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2016 award records by amount
NIH award records listing Detke, Michael J. as a PI. Multi-PI records show the full award amount for context.
- 1U01DA038879-01A1U01Contact PIEMB-001: A novel combination therapy for the treatment of cocaine-use disorder$4.1Maward amount
Award organization
Organizations that administered FY2016 awards listing Detke, Michael J. as a PI.
FY2016 award administered by Embera Neurotherapeutics, Inc. ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2016First NIH AwardEmbera Neurotherapeutics, Inc.
- 2016$500K Cumulative Funding
- 2016$1M Cumulative Funding
- 2016$2M Cumulative Funding
- 2016Entered Top 50% NationallyRanked #841
- 2016Entered Top 25% NationallyRanked #841
- 2016Entered Top 10% NationallyRanked #841
- 2016Entered Top 5% NationallyRanked #841
- 2018$5M Cumulative Funding